文献速递运动医学关节外科

术前肩关节僵硬与肩袖修复术后长期结局及肌腱炎症特征的关系

Preoperative Shoulder Stiffness Was Accompanied by Distinct Supraspinatus Tendon Inflammatory Signatures but Not Inferior Long-term Outcomes After Rotator Cuff Repair.
PubMed 文献 · Clin Orthop Relat Res · 2026-06-05

这项前瞻性队列研究纳入186例中型全层冈上肌腱撕裂行关节镜肩袖修复的患者,比较术前肩关节僵硬组与无僵硬组术后24个月的临床结局及肌腱组织学与转录组特征。结果显示,僵硬组在术后3、6、12、24个月达到MCID的比例更高,但两组最终功能无差异;僵硬组肌腱呈现炎症性肌腱病亚型的分子和组织学特征。

要点

  • 术前肩关节僵硬不增加肩袖修复术后24个月不良结局风险。
  • 僵硬组早期达到MCID的比例更高,反映基线功能更低、改善空间更大。
  • 僵硬组冈上肌腱显示炎症性肌腱病亚型特征和更多炎症细胞浸润。

核心结论

  • 在中型肩袖撕裂患者中,术前肩关节僵硬与关节镜肩袖修复术后长期结局较差无关。
  • 僵硬组虽然初始肩功能更差,但术后早期更可能达到临床有意义的改善,这反映基线功能更低而非最终恢复更优。
  • 僵硬组肌腱呈现独特的炎症性生物学特征。

研究设计与样本

  • 前瞻性观察性队列研究,2020年3月至2023年12月纳入474例拟行关节镜肩袖修复的患者,最终186例入组(僵硬组92例,无僵硬组94例),151例完成24个月随访分析(僵硬组75例,无僵硬组76例)。
  • 纳入标准为T2加权MRI确认的单侧全层冈上肌腱撕裂且前后径≤3 cm,无其他肩部病变。
  • 术前肩关节僵硬定义为被动前屈<120°、体侧外旋<30°或内旋低于L3水平,满足任一即归入僵硬组。

主要发现

  • 术后3个月,僵硬组达到MCID的比例在CMS(43% vs 13%,OR 4.9 [95%CI 2.2-11.0],p<0.001)、OSS(59% vs 21%,OR 5.3 [95%CI 2.6-10.9],p<0.001)和VAS-活动(33% vs 17%,OR 2.4 [95%CI 1.1-5.2],p=0.02)均高于无僵硬组。
  • 术后24个月,僵硬组CMS(100% vs 83%,OR 32.1 [95%CI 1.9-550.8],p<0.001)、OSS(99% vs 88%,OR 9.9 [95%CI 1.2-80.6],p=0.02)和VAS-活动(83% vs 68%,OR 2.2 [95%CI 1.0-4.7],p=0.04)的MCID达标比例仍更高,而VAS-静息和VAS-睡眠无组间差异。
  • 纵向分析显示两组CMS和OSS术后改善模式不同(组×时间交互:CMS ges=0.121,p<0.001;OSS ges=0.075,p<0.001),但校正基线评分后差异消失(CMS β 0.1 [95%CI -0.1至0.2],p=0.63)。
  • 僵硬组肌腱有254个上调基因和554个下调基因,富集于炎症性肌腱病亚型(NES 2.6,校正p<0.01),炎症细胞浸润和修订Bonar炎症评分更高;无僵硬组富集于缺氧-白色亚型(NES -2.8,校正p<0.01)及代谢、肌肉发育和神经发育通路。

关键数值与推荐

  • MCID阈值采用既往研究锚定值:CMS 10分,OSS 6分,VAS 1.4分。
  • 术前肩关节僵硬判定标准:被动前屈<120°、体侧外旋<30°或内旋低于L3水平,满足任一。
  • 再撕裂采用Sugaya分型评估,IV型和V型定义为术后再撕裂。

临床怎么用

  • 术前肩关节僵硬不应作为肩袖修复术的禁忌,可向患者说明长期结局与无僵硬者相当。
  • 僵硬患者术后早期功能改善幅度可能更大,但应理解这与基线功能较低有关,而非最终恢复更优。
  • 僵硬患者肌腱的炎症生物学特征可能提示需要关注围手术期炎症管理,但尚需进一步研究。

局限性

  • 僵硬组与无僵硬组的组间比较可能受基线功能差异影响,纵向分析校正基线后差异消失。
  • 研究中未报告再撕裂率的具体组间比较数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotator cuff tears with concomitant preoperative shoulder stiffness present a clinical challenge because the rehabilitation needed to restore motion may conflict with the protection typically used to support tendon healing after rotator cuff repair. Although recent studies suggest that preoperative stiffness may not be associated with inferior long-term outcomes, whether it is associated with a different pattern of postoperative improvement and distinct inflammatory features in the torn tendon remains unclear. QUESTIONS/PURPOSES: (1) Do a greater proportion of patients with preoperative shoulder stiffness achieve improvements in functional outcomes that exceed the minimum clinically important difference (MCID) at 3, 6, 12, and 24 months? (2) Do supraspinatus tendons from patients with shoulder stiffness show molecular and histologic features consistent with greater inflammation than tendons from patients without stiffness? METHODS: This prospective, observational cohort study included patients scheduled to undergo arthroscopic rotator cuff repair for unilateral rotator cuff tears with medium-sized, full-thickness supraspinatus tears, with or without concomitant preoperative shoulder stiffness. A medium-sized tear was defined as a supraspinatus tendon tear measuring 3 cm or less on preoperative coronal MRI. Preoperative shoulder stiffness was defined as passive shoulder ROM of less than 120° in forward flexion, less than 30° in external rotation at the side, or internal rotation lower than the L3 spinal level. Patients who met any one of these three criteria were assigned to the stiffness group. Between March 2020 and December 2023, 474 patients from both urban and rural areas who were scheduled to undergo repair for rotator cuff tears were evaluated at our shoulder pain specialty clinic. The inclusion criteria were: (1) full-thickness unilateral supraspinatus tendon tears measuring 3 cm or less in the AP dimension, confirmed on T2-weighted MRI, and (2) radiographs and MRI demonstrating no other shoulder pathology, including fracture, arthritis, dislocation, or glenoid labral tear. After strict eligibility assessment, 39% (186 of 474) of patients met all inclusion criteria and were enrolled into either the stiffness group (92 patients) or the without stiffness group (94 patients) based on predefined criteria. Specifically, 28% (135 of 474) of patients were excluded because symptom duration exceeded 12 months, 1% (2 of 474) were excluded because of missing MRI data, and 4% (20 of 474) were excluded because they had received more than three glucocorticoid injections. In addition, 18% (84 of 474) of patients were excluded because of systemic comorbidities or a history of surgery on the affected shoulder: rheumatoid arthritis in 1% (2 of 474), thyroid disorders in 3% (12 of 474), diabetes in 9% (43 of 474), gout in 1% (1 of 474), osteoporosis in 1% (5 of 474), hyperlipidemia in 4% (17 of 474), previous shoulder surgery in 1% (3 of 474), and concomitant upper limb fracture in 1% (1 of 474). A preoperative MRI evaluation resulted in the exclusion of patients with labral lesions (1% [5 of 474]), calcific tendinitis (1% [3 of 474]), massive tears (4% [21 of 474]), and partial-thickness tears (4% [18 of 474]). The enrolled cohort comprised 186 patients, with a mean age of 62 ± 7 years and a mean BMI of 24.1 ± 2.8 kg/m 2 . Women accounted for 68% (127 of 186) of the cohort. Of the 186 enrolled patients, 4% (8 of 186) were lost to follow-up by 12 months and an additional 15% (27 of 186) by 24 months, leaving 81% (151 of 186) for the final analysis; there were 75 patients with stiffness and 76 without stiffness. Clinical outcomes, including ROM, the VAS, Oxford shoulder score (OSS), and Constant-Murley Score (CMS), were assessed preoperatively and at 3, 6, 12, and 24 months postoperatively. MRI was performed preoperatively and at 24 months. Retears were assessed using the Sugaya classification at 24-month follow-up, with Types IV and V defined as postoperative retears. Intraoperative supraspinatus tendon samples were collected and analyzed using histology and bulk RNA sequencing. To address our first study question, we evaluated postoperative recovery at two levels. First, we applied anchor-based MCID thresholds reported in previous studies: 10 points for the CMS, 6 points for the OSS, and 1.4 points for the VAS. We then compared the proportions of patients in the two groups who achieved clinically meaningful improvement at each postoperative follow-up time point (3, 6, 12, and 24 months) to determine whether patients with preoperative stiffness were more likely to achieve meaningful improvement at scheduled follow-up visits. Second, we used repeated-measures ANOVA and mixed-effects models to analyze the longitudinal trajectories of the CMS and OSS across follow-up and to evaluate whether the postoperative pattern of improvement differed between groups. To address our second study question, supraspinatus tendon tissue was collected intraoperatively for histologic and bulk RNA sequencing. Histologic differences were assessed using the revised Bonar scoring system, and transcriptomic differences were evaluated using differential gene expression and functional enrichment analyses. RESULTS: At 3 months, a greater proportion of patients in the stiffness group achieved the MCID in the CMS (43% [32 of 75] versus 13% [10 of 76], OR 4.9 [95% CI 2.2 to 11.0]; p < 0.001), OSS (59% [44 of 75] versus 21% [16 of 76], OR 5.3 [95% CI 2.6 to 10.9]; p < 0.001), and VAS-movement (33% [25 of 75] versus 17% [13 of 76], OR 2.4 [95% CI 1.1 to 5.2]; p = 0.02). Similar patterns were observed at 6 and 12 months, with higher proportions of patients in the stiffness group achieving clinically meaningful improvement across the CMS, OSS, and VAS-movement. By 24 months, the patients with stiffness still had higher MCID achievement proportions for the CMS (100% [75 of 75] versus 83% [63 of 76], OR 32.1 [95% CI 1.9 to 550.8]; p < 0.001), OSS (99% [74 of 75] versus 88% [67 of 76], OR 9.9 [95% CI 1.2 to 80.6]; p = 0.02), and VAS-movement (83% [62 of 75] versus 68% [52 of 76], OR 2.2 [95% CI 1.0 to 4.7]; p = 0.04), whereas we found no differences between groups for VAS-rest or VAS-sleep at any follow-up timepoint. Longitudinal analyses showed different postoperative improvement patterns for the CMS and OSS between groups (group-by-time interaction: CMS, ges = 0.121; p < 0.001; OSS, ges = 0.075; p < 0.001), although these differences were no longer observed after adjustment for baseline score (CMS: β 0.1 [95% CI -0.1 to 0.2]; p = 0.63). With respect to tendon biology, patients with and without preoperative stiffness showed different molecular and histologic features. The patients with stiffness had 254 upregulated genes and 554 downregulated genes, were enriched in the inflammatory tendinopathy subtype (NES 2.6; adjusted p < 0.01), and showed more inflammatory cell infiltration and higher revised Bonar inflammation scores. By contrast, the patients without stiffness were enriched in the hypoxia-white subtype (NES -2.8; adjusted p < 0.01) and in metabolic, muscle-development, and neurodevelopment pathways. Immune deconvolution also supported a more immune-activated tendon microenvironment in the patients with stiffness. CONCLUSION: In patients with medium-sized rotator cuff tears, preoperative shoulder stiffness was not associated with worse long-term outcomes after arthroscopic rotator cuff repair. Although patients with stiffness started with worse shoulder function, they were more likely to achieve clinically meaningful improvement during the early postoperative period, a pattern that likely reflects lower baseline function and greater room for improvement rather than superior final recovery. In addition, inflammatory tendon features from patients with shoulder stiffness reflected a distinct biologic context. For surgeons, these findings may help when counseling patients with rotator cuff tears that satisfactory recovery is achievable even with concomitant preoperative shoulder stiffness. Future work should focus on whether this inflammatory tendon feature can be validated in broader patient populations and can be used to refine biologic classification and postoperative management. LEVEL OF EVIDENCE: Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Liu M, Cai H, Tang C, et al. Preoperative Shoulder Stiffness Was Accompanied by Distinct Supraspinatus Tendon Inflammatory Signatures but Not Inferior Long-term Outcomes After Rotator Cuff Repair. Clin Orthop Relat Res. 2026. PMID: 42248213. doi:10.1097/CORR.0000000000004010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。